Navigation Links
Quest Introduces Its Next Generation AlphaView 4MP Medical LCD

IRVINE, Calif., Oct. 17, 2011 /PRNewswire/ -- Quest International, Inc., a leading global supplier of information technology solutions and imaging display technologies, today announced the release of the AlphaView® AVC4, a color medical diagnostic display for healthcare professionals. The AVC4 is a 30 inch diagonal, 4-megapixel (MP) medical-grade LCD designed for use in applications involving Picture Archiving and Communication System (PACS) and radiology, where a high quality and cost effective DICOM compliant monitor is ideal.

Combining the features of diagnostic displays, with the advantages of large screen LCDs, the AlphaView AVC4 features many advanced features, including two DVI-D and two DisplayPort inputs, allowing it to drive two 2MP images simultaneously, without a center bezel.

Featuring maximum luminance of 350 cd/m2 and a 1000:1 contrast ratio, the AVC4 provides outstanding image quality for radiology reading rooms, as well as in high brightness environments such as OR, ER and surgical suites. The AVC4's ambient light sensor automatically adjusts the display's brightness based on lighting conditions.

The AVC4 includes factory-adjusted DICOM calibration with self-monitoring brightness to maintain a specific luminance that can be set by the user. Its digital uniformity correction technology reduces screen uniformity errors and compensates for differences in color/grayscale and luminance across the screen.

Unlike other large screen LCDs available to the medical professional, the AVC4's multi-directional controls allow for ease of use in either landscape or portrait modes.

The AVC4 comes standard with an industry leading five-year overnight hot-swap warranty.

AlphaView offers a complete line of cost effective medical imaging, diagnostic and surgical displays available exclusively through Quest International.

About Quest International, Inc.
Quest International, Inc. is a global supplier of imaging display technologies and information technology solutions in the healthcare industry. Since 1982 Quest's IT Solutions teams and Imaging Professionals have provided in-depth expertise, service and solutions to hospitals, imaging centers, and healthcare OEMs.

ISO 9001:2008, 13485:2003 14001:2004, and ANSI/ESD S20.20-2007 registered, Quest International has twice been awarded Siemens Healthcare's Best Global Supplier of the Year Award and GE Healthcare's Repair Supply Chain Excellence Award. Quest continuously strives to deliver quality, service and value to every customer.

For more information, please visit or email Quest International at

SOURCE Quest International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics to Release Third Quarter 2011 Financial Results
2. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
3. Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index™
4. Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011
5. St. Jude Childrens Research Hospital Discovery Aided Quest for Adult Cancer Drug
6. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
7. PCAN Calls On Federal Government to Reconsider Preliminary Approval of Texas Medicaid Waiver Request
8. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
9. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
10. Questcor Provides Updated New Paid Prescription Trends
11. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... -- --> --> ... das Patent über eine neue Hepatitis-B-Behandlung, welches sie gemeinsam ... Enyo Pharma vergeben haben. Im Rahmen ... von Edelris gemeinsam mit seinen Partnern Inserm und Poxel ... identifiziert, und es wurden neue Inhaltsstoffe entdeckt, die zu ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... , ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David ... 130884WC. , According to court documents, Adcock testified that on May 10, 2010 he ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Beddit® has launched ... Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that rates ... how well you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development and ... of its current state of the art research, development and manufacturing facility outside ... its manufacturing capacity as well as to support its clients’ growing research and ...
(Date:11/25/2015)... ... 2015 , ... Since its launch in 2012, the Regenestem ... cell therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent ... (RTM). , Organizations are required to hold a registered trademark in order to ...
Breaking Medicine News(10 mins):